VIEMED HEALTHCARE, INC.
VMDNasdaqHealthcare · Services-Misc Health & Allied Services, NEC · A1 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $270.3M | $224.3M | $183.0M | $138.8M | $117.1M | $131.3M |
| Operating income | $22.9M | $17.9M | $14.3M | $8.3M | $11.6M | $26.8M |
| Net income | $14.9M | $11.3M | $10.2M | $6.2M | $9.1M | $31.5M |
| Total assets | $199.2M | $177.1M | $154.9M | $117.0M | $118.0M | $112.6M |
| Total liabilities | $55.6M | $43.8M | $41.0M | $19.9M | $23.1M | $30.9M |
| Equity | $141.5M | $131.4M | $113.9M | $97.1M | $94.8M | $81.7M |
| EPS (diluted) | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 | $0.78 |
| Shares out. | 39.5M | 38.8M | 38.2M | 39.7M | 39.6M | 38.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 8.5%
- Net margin
- 5.5%
- Return on equity
- 10.6%
- Return on assets
- 7.5%
- Return on capital (ROCE)
- 14.5%
- Liabilities / assets
- 27.9%
- Debt / equity
- 0.39×
- Book value / share
- $3.58
- Revenue growth (YoY)
- 20.5%
- Net income growth (YoY)
- 32.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 5.38safe
- Accruals / assets
- −18.6%clean
- Beneish M-Score
- -3.19normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Forager Capital Management, LlcPassive (13G)Nov 7, 2025
- Blackrock Portfolio Management LlcPassive (13G)Jul 15, 2025
- Thrivent Financial For LutheransPassive (13G)Apr 29, 2025
- Blackrock, Inc.Passive (13G)Apr 23, 2025
- Nantahala Capital Management, LlcPassive (13G)Nov 14, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Moore MichaelOfficer — President | Mar 18, 2026 | Sell | 31,570 | $9.42 |
| Hoyt CaseyOfficer — Chief Executive Officer | Jan 29, 2026 | Option exercise | 39,795 | — |
| Cambre JeromeOfficer — Vice President of Sales | Jan 29, 2026 | Option exercise | 8,619 | — |
| Moore MichaelOfficer — President | Jan 29, 2026 | Option exercise | 26,842 | — |
| Trahan JeremyOfficer — General Counsel | Jan 29, 2026 | Option exercise | 10,774 | — |
| Frazier WilliamOfficer — Chief Medical Officer | Jan 29, 2026 | Option exercise | 2,334 | — |
| Fitzgerald TraeOfficer — Chief Financial Officer | Jan 29, 2026 | Option exercise | 9,794 | — |
| Zehnder William ToddOfficer — Chief Operating Officer | Jan 29, 2026 | Option exercise | 26,842 | — |
| Frazier WilliamOfficer — Chief Medical Officer | Jan 21, 2026 | Option exercise | 3,401 | — |
| Moore MichaelOfficer — President | Jan 21, 2026 | Option exercise | 34,214 | — |
| Hoyt CaseyOfficer — Chief Executive Officer | Jan 21, 2026 | Option exercise | 49,597 | — |
| Zehnder William ToddOfficer — Chief Operating Officer | Jan 21, 2026 | Option exercise | 117,548 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 408,565 | 1.3 | -8.6% |
| Apr 30, 2026 | 447,066 | 2.0 | +27.2% |
| Apr 15, 2026 | 351,498 | 1.2 | -10.0% |
| Mar 31, 2026 | 390,743 | 1.1 | -13.2% |
| Mar 13, 2026 | 450,066 | 1.1 | +29.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 5, 2026
- Regulation FD disclosureMar 16, 2026
- Results of operations · Regulation FD disclosure · Other material eventMar 4, 2026
- Entered a material agreement · Regulation FD disclosureNov 7, 2025
- Results of operationsNov 5, 2025
- Regulation FD disclosure · Other material eventSep 23, 2025
- Results of operationsAug 6, 2025
- Regulation FD disclosureJul 2, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.